Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
The FDA announced that Ozempic and Wegovy supply problems had ended and set final deadlines for pharmacies to stop making compounded semaglutide: Individual pharmacy locations: Required to stop by April 22, 2025 Commercial compounding operations: Discontinue production by May 22, 2025 So, compounded semaglutide was not available after May 22, 2025, except in exceptional medical circumstances where standard formulations are ineffective
However, careful clinical assessment is needed before initiating therapy, particularly regarding gastrointestinal function and concurrent MS medications
They add that the new pill provides more options for patients
The current retail prices for Ozempic, Wegovy, and Rybelsus are between $1,300 and $1,900 monthly
Appointments with trained clinicians who review labs, discuss risks, and personalize your semaglutide plan
